CN108478852A - A kind of pharmaceutical products, the carrier for loading pharmaceutical products, hydrogel and its method - Google Patents
A kind of pharmaceutical products, the carrier for loading pharmaceutical products, hydrogel and its method Download PDFInfo
- Publication number
- CN108478852A CN108478852A CN201810308852.5A CN201810308852A CN108478852A CN 108478852 A CN108478852 A CN 108478852A CN 201810308852 A CN201810308852 A CN 201810308852A CN 108478852 A CN108478852 A CN 108478852A
- Authority
- CN
- China
- Prior art keywords
- hydrogel
- silk
- hydrogen peroxide
- silk fibroin
- pharmaceutical products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 81
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000000825 pharmaceutical preparation Substances 0.000 title claims abstract description 26
- 229940127557 pharmaceutical product Drugs 0.000 title claims abstract description 25
- 238000011068 loading method Methods 0.000 title claims abstract description 9
- 238000004132 cross linking Methods 0.000 claims abstract description 17
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- 239000012620 biological material Substances 0.000 claims abstract description 8
- 239000000499 gel Substances 0.000 claims abstract description 7
- 108010022355 Fibroins Proteins 0.000 claims description 71
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 52
- 239000000463 material Substances 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 27
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000007864 aqueous solution Substances 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical group [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 8
- 239000003431 cross linking reagent Substances 0.000 claims description 7
- 239000006185 dispersion Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 239000003102 growth factor Substances 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
- 239000000730 antalgic agent Substances 0.000 claims description 3
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000005660 chlorination reaction Methods 0.000 claims 1
- 230000002797 proteolythic effect Effects 0.000 claims 1
- 238000009418 renovation Methods 0.000 claims 1
- 230000009471 action Effects 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 241000255789 Bombyx mori Species 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000017423 tissue regeneration Effects 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229940124350 antibacterial drug Drugs 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000011148 calcium chloride Nutrition 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 229940127554 medical product Drugs 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 108091000100 Tyrosine Phenol-Lyase Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000009849 vacuum degassing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0033—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0038—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/16—Halogen-containing compounds
- C08K2003/162—Calcium, strontium or barium halides, e.g. calcium, strontium or barium chloride
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/16—Halogen-containing compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
一种药学制品、用于负载医药制品的载体、水凝胶及其方法,属于凝胶领域。水凝胶是一种通过是蛋白质在酶的作用下进行交联反应而获得一种能够被以注射的方式使用的透明的生物材料。其具有好的弹性、生物相容性,应用前景广阔。
A pharmaceutical product, a carrier for loading the pharmaceutical product, a hydrogel and a method thereof, belonging to the gel field. Hydrogel is a transparent biomaterial that can be injected by cross-linking proteins under the action of enzymes. It has good elasticity and biocompatibility, and has broad application prospects.
Description
技术领域technical field
本发明涉及凝胶材料领域,具体而言,涉及一种水凝胶及其方法。The invention relates to the field of gel materials, in particular to a hydrogel and a method thereof.
背景技术Background technique
丝素蛋白来源丰富、成本低廉,其主要的组成成分为氨基酸,同时它还具有无刺激性、良好的溶氧渗透性,可控的生物降解性。丝素蛋白在体外可支持各种细胞黏附、生长和分化;在体内,丝素蛋白同样具备良好组织相容性。因此,丝素蛋白在组织工程、生物医学、药物缓释和光学影像学领域有着广泛的应用。在近期,丝素蛋白已被FDA批准可用于临床医学。然而,未经处理的再生丝素材料由于含有大量的无规卷曲结构而易溶于水,需要通过物理或化学的方法进行改性处理才能实际应用。经过物理改性(乙醇浸泡、pH、高温和金属离子等)的丝素膜脆性较大,柔韧性差,无法弯曲折叠。而化学处理方式通过在丝素分子内部和分子间形成共价键结合的网状结构,可有效改善薄膜的稳定性和力学性能。然而常见的化学交联试剂如戊二醛、二缩水甘油醚会带来一定的细胞毒性,限制了其在生物材料领域方面的应用。Silk fibroin is rich in sources and low in cost. Its main components are amino acids, and it also has non-irritating, good dissolved oxygen permeability, and controllable biodegradability. Silk fibroin can support various cell adhesion, growth and differentiation in vitro; in vivo, silk fibroin also has good tissue compatibility. Therefore, silk fibroin has a wide range of applications in the fields of tissue engineering, biomedicine, drug sustained release and optical imaging. Recently, silk fibroin has been approved by the FDA for clinical use. However, the untreated regenerated silk fibroin material is easily soluble in water due to its large random coil structure, and it needs to be modified by physical or chemical methods before it can be practically applied. After physical modification (ethanol immersion, pH, high temperature and metal ions, etc.), the silk fibroin film is more brittle, has poor flexibility, and cannot be bent and folded. The chemical treatment method can effectively improve the stability and mechanical properties of the film by forming a covalently bonded network structure within and between the silk fibroin molecules. However, common chemical cross-linking reagents such as glutaraldehyde and diglycidyl ether can cause certain cytotoxicity, which limits their application in the field of biomaterials.
随着生物技术在高分子材料中的功能改性研究日益深入,以酶促技术改善丝素材料性能的的研究报道屡见不鲜。中国发明专利“一种酶法制备丝素/弹性蛋白复合膜材料的方法”(公开号CN 105218842A)应用β-酪氨酸酶对丝素中的氨基酸转化,增加丝素中酪氨酸残基的数量,继而借助酪氨酸酶催化氧化丝素与弹性蛋白交联,制备了丝素/弹性蛋白薄膜。但其中氨基酸转化过程中使用了苯酚,其残留会影响材料的生物相容性。With the deepening of biotechnology research on the functional modification of polymer materials, the research reports on improving the properties of silk fibroin materials by enzymatic technology are not uncommon. Chinese invention patent "A method for preparing silk fibroin/elastin composite membrane material by enzymatic method" (publication number CN 105218842A) uses β-tyrosinase to convert amino acids in silk fibroin, increasing tyrosine residues in silk fibroin The amount of silk fibroin/elastin film was prepared by tyrosinase-catalyzed oxidation of silk fibroin and elastin cross-linking. However, phenol is used in the amino acid conversion process, and its residue will affect the biocompatibility of the material.
水凝胶是一类具有三维聚合物网络结构的特殊材料,能够吸收大量的水分,溶胀同时还能保持原有结构不被溶解。目前广泛应用于药物缓释、组织工程材料、人工皮肤、可注射材料等方面。目前,丝素通过物理方法(超声、改变pH、表面活性剂诱导等)和化学方法(添加戊二醛、二缩水甘油醚等)可制备获得丝素水凝胶,然而物理方法制备的水凝胶耗时长,β-折叠结构增加,最终形成乳白色的水凝胶且弹性较差。化学的方法形成的水凝胶弹性较好,但是带入体系的化学小分子需要二次去除,生物相容性差,难以作为可注射到体内的生物材料。Hydrogel is a special material with a three-dimensional polymer network structure, which can absorb a large amount of water, swell and keep the original structure from being dissolved. At present, it is widely used in drug sustained release, tissue engineering materials, artificial skin, injectable materials, etc. At present, silk fibroin hydrogels can be prepared by physical methods (ultrasound, changing pH, surfactant induction, etc.) The glue takes a long time, the β-sheet structure increases, and finally forms a milky white hydrogel with poor elasticity. The hydrogel formed by chemical method has better elasticity, but the chemical small molecules brought into the system need to be removed twice, and the biocompatibility is poor, so it is difficult to be used as a biomaterial that can be injected into the body.
公开于该背景技术部分的信息仅仅旨在加深对发明的总体背景技术的理解,而不应当被视为承认或以任何形式暗示该信息构成已为本领域技术人员所公知的现有技术。The information disclosed in this background section is only intended to enhance the understanding of the general background of the invention, and should not be considered as an acknowledgment or any form of suggestion that the information constitutes the prior art that is already known to those skilled in the art.
发明内容Contents of the invention
基于现有技术的不足,本发明提供了一种药学制品、用于负载医药制品的载体、水凝胶及其方法,以部分或全部地改善、甚至解决以上问题。Based on the deficiencies of the prior art, the present invention provides a pharmaceutical product, a carrier for loading the pharmaceutical product, a hydrogel and a method thereof, so as to partially or completely improve or even solve the above problems.
本发明是这样实现的:The present invention is achieved like this:
在第一方面,本发明实施例的提供了一种水凝胶。In a first aspect, embodiments of the present invention provide a hydrogel.
水凝胶是一种能够被以注射的方式使用的生物材料,水凝胶是通过采用复合交联剂使包含于原料中的蛋白质交联而成,其中,蛋白质含有酪氨酸,复合交联剂包括辣根过氧化酶(Peroxidase Horseradish,HRP)和双氧水。Hydrogel is a biomaterial that can be used by injection. The hydrogel is formed by cross-linking the protein contained in the raw material by using a complex cross-linking agent. Among them, the protein contains tyrosine, and the complex cross-linking Agents include horseradish peroxidase (Peroxidase Horseradish, HRP) and hydrogen peroxide.
在第二方面,本发明实施例的提供了一种用于负载医药制品的载体。In the second aspect, the embodiments of the present invention provide a carrier for carrying medical products.
用于负载医药制品的载体由水凝胶制作而成,其中,医药制品包括抗菌药、止痛药以及生长因子中的一种或多种。The carrier for loading medical products is made of hydrogel, wherein the medical products include one or more of antibacterial drugs, analgesics and growth factors.
在第三方面,本发明实施例的提供了一种药学制品。In a third aspect, the embodiments of the present invention provide a pharmaceutical preparation.
药学制品由水凝胶制作而成,其中药学制品包括敷料、体内可注射材料、体内填充物、组织修复材料、隔离材料。Pharmaceutical products are made of hydrogel, and pharmaceutical products include dressings, injectable materials in vivo, fillers in vivo, tissue repair materials, and isolation materials.
在第四方面,本发明实施例提供了一种制备水凝胶的方法。In a fourth aspect, embodiments of the present invention provide a method for preparing a hydrogel.
制作方法包括:向分散有从原料中获得的蛋白质的分散液中加入辣根过氧化酶使蛋白质溶解,再加入双氧水进行交联反应。The preparation method comprises: adding horseradish peroxidase to the dispersion liquid in which the protein obtained from raw materials is dispersed to dissolve the protein, and then adding hydrogen peroxide to carry out cross-linking reaction.
有益效果:Beneficial effect:
本发明实施例提供的水凝胶是一种酶交联水凝胶,其具有一定的透明度,并且具有可注射性、良好的弹性以及良好的细胞相容性。水凝胶可以直接用于各类创伤的表面(如烧伤、溃疡、褥疮等),起到促进创面愈合和隔离保护的作用。此外,水凝胶还可以作为药物载体,负载各类抗菌药、止痛药以及生长因子,对药物起到缓释作用,对于创面可起到防止感染、止痛以及促进愈合的作用。用于制作水凝胶的材料中,基质(含蛋白质的原料)和酶促交联的成分均可且优选为天然生物来源,从而可以使获得水凝胶安全可靠,方便灭菌。并且,由此可作为医用敷料,体内可注射材料,体内可填充物以及用于组织修复等领域,具有良好的应用前景。The hydrogel provided in the embodiment of the present invention is an enzyme-crosslinked hydrogel, which has certain transparency, injectability, good elasticity and good cell compatibility. The hydrogel can be directly used on the surface of various wounds (such as burns, ulcers, bedsores, etc.) to promote wound healing and isolation protection. In addition, hydrogel can also be used as a drug carrier, loaded with various antibacterial drugs, analgesics and growth factors, to release drugs slowly, and to prevent infection, relieve pain and promote healing of wounds. Among the materials used to make the hydrogel, both the matrix (protein-containing raw material) and the enzymatic cross-linking components can be and are preferably natural biological sources, so that the hydrogel can be obtained safely, reliably and conveniently sterilized. Moreover, it can be used as a medical dressing, an injectable material in the body, a filler in the body, and used in tissue repair and other fields, and has a good application prospect.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,以下将对实施例或现有技术描述中所需要使用的附图作简单地介绍。In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the following will briefly introduce the drawings that need to be used in the description of the embodiments or the prior art.
图1为本发明实施例1~5的丝素水凝胶的实物图;Fig. 1 is the physical figure of the silk fibroin hydrogel of embodiment 1~5 of the present invention;
图2为本发明实施例1~3中的水凝胶材料的凝胶时间图;Fig. 2 is the gelation time figure of the hydrogel material in the embodiment of the present invention 1~3;
图3为本发明实施例2中不同状态下的水凝胶的透光度图。Fig. 3 is a light transmittance diagram of hydrogels in different states in Example 2 of the present invention.
具体实施方式Detailed ways
下面将结合实施例对本发明的实施方案进行详细描述,但是本领域技术人员将会理解,下列实施例仅用于说明本发明,而不应视为限制本发明的范围。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。Embodiments of the present invention will be described in detail below in conjunction with examples, but those skilled in the art will understand that the following examples are only for illustrating the present invention, and should not be considered as limiting the scope of the present invention. Those who do not indicate the specific conditions in the examples are carried out according to the conventional conditions or the conditions suggested by the manufacturer. The reagents or instruments used were not indicated by the manufacturer, and they were all conventional products that could be purchased from the market.
以下针对本发明实施例的药学制品、用于负载医药制品的载体、水凝胶及其方法进行具体说明:The pharmaceutical products, the carrier for loading the pharmaceutical products, the hydrogel and the method thereof are described in detail below:
本发明实施例提供的水凝胶是一种能够被以注射的方式使用的生物材料。水凝胶是通过采用复合交联剂使包含于原料中的蛋白质交联而成,其中,蛋白质含有酪氨酸,复合交联剂包括辣根过氧化酶和双氧水。The hydrogel provided by the embodiment of the present invention is a biomaterial that can be used in an injection. The hydrogel is formed by cross-linking the protein contained in the raw material by using a composite cross-linking agent, wherein the protein contains tyrosine, and the composite cross-linking agent includes horseradish peroxidase and hydrogen peroxide.
在水凝胶的制作原料中,辣根过氧化酶在微量双氧水的辅助作用下,能够催化丝素中的酪氨酸残基生成酚氧自由基,引发丝素分子之间的交联,在短时间内,反应体系可形成凝胶。Among the raw materials for making hydrogels, horseradish peroxidase, assisted by a small amount of hydrogen peroxide, can catalyze the tyrosine residues in silk fibroin to generate phenolic oxygen free radicals, triggering cross-linking between silk fibroin molecules. In a short time, the reaction system can form a gel.
其中的原料可以是各种生物材料,例如,蚕丝,其可来源于家蚕、柞蚕、天蚕等不同类型的蚕。原料除了可以是作为原始材料的蚕丝,还可以是由蚕丝进行加工后的产品,例如,丝素、胶原、明胶中的一种或多种。The raw material therein can be various biological materials, for example, silk, which can be derived from different types of silkworms such as silkworm, tussah silkworm, and celestial silkworm. The raw material may not only be silk as a raw material, but also a product processed from silk, for example, one or more of silk fibroin, collagen, and gelatin.
如同前述,本发明实施例提供的水凝胶在医学和药学等领域具有广阔的应用前景。As mentioned above, the hydrogel provided by the embodiments of the present invention has broad application prospects in the fields of medicine and pharmacy.
例如,在一些示例中,水凝胶被作为一种载体使用,通过将获得水凝胶直接塑形或者通过添加其他药学上可接受的辅料制作为具有一定的形态的载体。通过将医药制品负载在载体上,可以达到提高医药制品的用药效率和安全性。其中的医药制品包括抗菌药、止痛药以及生长因子中的一种或多种。上述将医药制品负载在载体上可以是直接将医药制品(粉体、片剂、喷雾等形式)分散(涂覆、喷洒等方式)在水凝胶的表面或内部。For example, in some examples, the hydrogel is used as a carrier, and the obtained hydrogel is directly shaped or made into a carrier with a certain shape by adding other pharmaceutically acceptable excipients. By loading the pharmaceutical products on the carrier, the medication efficiency and safety of the pharmaceutical products can be improved. The pharmaceutical products include one or more of antibacterial drugs, pain relievers and growth factors. The aforementioned loading of the pharmaceutical product on the carrier may be directly dispersing (coating, spraying, etc.) the pharmaceutical product (in the form of powder, tablet, spray, etc.) on the surface or inside of the hydrogel.
在此之外,除了将水凝胶作为如上述的载体使用之外,水凝胶还可以直接作为一种药学制品使用。即药学制品由水凝胶制作而成。其中,药学制品包括敷料、体内可注射材料、体内填充物、组织修复材料、隔离材料。In addition, in addition to using the hydrogel as a carrier as described above, the hydrogel can also be directly used as a pharmaceutical product. That is, the pharmaceutical product is made of hydrogel. Among them, pharmaceutical products include dressings, injectable materials in the body, fillers in the body, tissue repair materials, and isolation materials.
在本发明实施例中还提供了一种水凝胶的制作方法。所述的制作方法包括:向分散有从原料中获得的蛋白质的分散液中加入辣根过氧化酶使蛋白质溶解,再加入双氧水进行交联反应。In the embodiment of the present invention, a method for making the hydrogel is also provided. The preparation method comprises: adding horseradish peroxidase to the dispersion liquid in which the protein obtained from raw materials is dispersed to dissolve the protein, and then adding hydrogen peroxide to carry out cross-linking reaction.
在一些示例中,前述之分散液为丝素水溶液,原料为蚕丝,蛋白质为丝素。特别地,丝素水溶液可通过以下方法制作:使脱胶后的蚕丝溶解在水中。In some examples, the aforementioned dispersion liquid is an aqueous solution of silk fibroin, the raw material is silk, and the protein is silk fibroin. In particular, the aqueous silk fibroin solution can be prepared by dissolving degummed silk in water.
当制作水凝胶的原料采用蚕丝时,使脱胶后的蚕丝溶解在水中的方法包括:将蚕丝脱胶后获得丝素纤维溶解于溶剂中,其中,溶剂为溴化锂水溶液或三元水溶液。When silk is used as the raw material for making the hydrogel, the method for dissolving degummed silk in water includes: dissolving silk fibroin fibers obtained after degumming silk in a solvent, wherein the solvent is lithium bromide aqueous solution or ternary aqueous solution.
一种可替代的示例中,三元水溶液由氯化钙、乙醇以及水组成。优选的是,三元水溶液是由氯化钙、乙醇以及水按照1:2:8的摩尔比配制而成。溴化锂水溶液的浓度可以被选择为9.3mol/L。In an alternative example, the ternary aqueous solution consists of calcium chloride, ethanol and water. Preferably, the ternary aqueous solution is prepared from calcium chloride, ethanol and water in a molar ratio of 1:2:8. The concentration of the lithium bromide aqueous solution can be selected to be 9.3 mol/L.
另外,为了促进丝素纤维的溶解,在一种可选的示例中,丝素纤维是在加热的条件下溶解于溶剂的,其中,加热的温度为50~80℃,进一步优选为50~70℃、最优选为70~75℃。In addition, in order to promote the dissolution of silk fibers, in an optional example, silk fibers are dissolved in a solvent under heating conditions, wherein the heating temperature is 50-80°C, more preferably 50-70°C. °C, most preferably 70 to 75 °C.
前述的交联反应较佳地通过在加热条件下进行。优选地,加入双氧水后进行加热反应,且加热反应的条件为:温度10~50℃、丝素浓度为1~8%、辣根过氧化酶5~20U/mL、双氧水0.05~10mg/mL、时间10~120min。The aforementioned crosslinking reaction is preferably carried out under heating conditions. Preferably, heating reaction is carried out after adding hydrogen peroxide, and the conditions of heating reaction are: temperature 10-50°C, silk fibroin concentration 1-8%, horseradish peroxidase 5-20U/mL, hydrogen peroxide 0.05-10mg/mL, The time is 10-120 minutes.
更佳地,在加入双氧水之后,进行催化交联反应之前,制作方法还包括将分散液、辣根过氧化酶以及双氧水的共混体系通过真空脱泡处理。More preferably, after the hydrogen peroxide is added and before the catalyzed cross-linking reaction, the preparation method further includes vacuum defoaming the blended system of the dispersion liquid, horseradish peroxidase and hydrogen peroxide.
需要说明的是,在水凝胶的制作过程中,水凝胶的透明度和弹性模量可根据丝素浓度进行调整。同时,制作过程中的交联反应时间可以通过辣根过氧化酶浓度、双氧水浓度以及作用温度进行控制。It should be noted that in the process of making the hydrogel, the transparency and elastic modulus of the hydrogel can be adjusted according to the concentration of silk fibroin. At the same time, the cross-linking reaction time in the production process can be controlled by the concentration of horseradish peroxidase, hydrogen peroxide concentration and action temperature.
作为一种实例,采用蚕丝制作水凝胶。As an example, silk is used to make hydrogels.
包括以下步骤:(a)对天然蚕丝进行脱胶,用溴化锂或者三元溶液溶解脱胶后的蚕丝,再经过透析、过滤、浓缩,得到丝素水溶液(原液);(b)用超纯水配制(稀释原液)一定浓度的丝素水溶液,依次加入辣根过氧化酶和双氧水水溶液,混合均匀;(c)将共混体系真空脱泡后,置于一定的温度条件下即可得到丝素水凝胶。The method comprises the following steps: (a) degumming natural silk, dissolving the degummed silk with lithium bromide or a ternary solution, and then dialysis, filtering and concentrating to obtain silk fibroin aqueous solution (stock solution); (b) preparing ( Dilute stock solution) a certain concentration of silk fibroin aqueous solution, add horseradish peroxidase and hydrogen peroxide aqueous solution in turn, and mix evenly; (c) after vacuum degassing the blend system, put it under a certain temperature condition to obtain silk fibroin hydrogel glue.
其中,步骤(a)中丝素水溶液的制备方法具体为:将脱胶后的丝素纤维置于CaCl2-乙醇-水三元溶液或者9.3mol/L溴化锂溶液中,加热使溶液的温度控制在50~80℃之间,搅拌至溶解,然后以去离子水透析36~72h,经过过滤、离心除杂,风干浓缩得到丝素水溶液,所述CaCl2-乙醇-水三元溶液中CaCl2、乙醇、水三者的物质量之比为1:2:8。Wherein, the preparation method of silk fibroin aqueous solution in the step (a) is specifically: place the silk fibroin fiber after degumming in CaCl2-ethanol-water ternary solution or 9.3mol/L lithium bromide solution, heating makes the temperature of solution be controlled at 50 ~80°C, stirred until dissolved, then dialyzed with deionized water for 36~72h, filtered, centrifuged to remove impurities, air-dried and concentrated to obtain silk fibroin aqueous solution, the CaCl 2 -ethanol-water ternary solution contained CaCl 2 , ethanol The ratio of the material quantity of water and water is 1:2:8.
按照上述方案,步骤(b)中丝素质量浓度为1~8%,辣根过氧化酶5~20U/ml,双氧水2~20mg/ml。According to the above scheme, the mass concentration of silk fibroin in step (b) is 1-8%, horseradish peroxidase is 5-20 U/ml, and hydrogen peroxide is 2-20 mg/ml.
按照上述方案,步骤(c)中室温充分搅拌均匀后真空脱泡,混合溶液注入模具中后,处理温度范围10~50℃,时间10~120min,即可得到成型的丝素水凝胶。According to the above scheme, in step (c), stir well at room temperature and then vacuum defoam, inject the mixed solution into the mold, and process at a temperature ranging from 10 to 50°C for 10 to 120 minutes to obtain a shaped silk fibroin hydrogel.
根据检验,发明人确信,本发明实施例提供的水凝胶具有包括但不限于以下的各种优点:According to the test, the inventors believe that the hydrogel provided by the embodiments of the present invention has various advantages including but not limited to the following:
(1)以天然可再生的高分子材料丝素为原料,材料来源广泛且为天然可降解高分子,降解产物具有良好的生物相容性和低免疫原性。(1) The natural renewable polymer material silk fibroin is used as the raw material. The material has a wide range of sources and is a natural degradable polymer. The degradation product has good biocompatibility and low immunogenicity.
(2)采用酶促交联方式,通过酪氨酸残基生成的酚氧自由基在丝素大分子之间形成了稳定的共价交联键,促进了丝素水凝胶的快速形成,其稳定性好,扩展其在生物材料的应用范围。(2) Using enzymatic cross-linking, the phenolic oxygen free radicals generated by tyrosine residues form stable covalent cross-links between silk fibroin macromolecules, which promotes the rapid formation of silk fibroin hydrogels, It has good stability and expands its application range in biological materials.
(3)本发明最终制备的丝素水凝胶通过控释制备条件,可得到具有弹性的透明可注射水凝胶。(3) The silk fibroin hydrogel finally prepared in the present invention can obtain elastic transparent injectable hydrogel through controlled release preparation conditions.
(4)本发明提供的可注射水凝胶制备工艺简单易行,条件易于控制,可通过过滤灭菌,具有较好的应用前景。(4) The preparation process of the injectable hydrogel provided by the present invention is simple and easy, the conditions are easy to control, and it can be sterilized by filtration, so it has a good application prospect.
以下结合实施例对本发明的药学制品、用于负载医药制品的载体、水凝胶及其方法作进一步的详细描述。The pharmaceutical product, the carrier for loading the pharmaceutical product, the hydrogel and the method thereof of the present invention will be further described in detail in conjunction with the examples below.
实施例1Example 1
一种丝素水凝胶材料,由下述制备方法制备而得。A silk fibroin hydrogel material is prepared by the following preparation method.
首先将天然蚕丝依次经过脱胶、溶解、透析、过滤和浓缩得到质量分数为4%的丝素水溶解。其中,溶解过程是将脱胶后得到的丝素纤维与CaCl2-乙醇-水组成的三元溶液混合,在75℃的温度条件下保温0.5h;三元溶液中,CaCl2、乙醇和水的物质的量比为1:2:8。Firstly, the natural silk is degummed, dissolved, dialyzed, filtered and concentrated to obtain silk fibroin with a mass fraction of 4%. Among them, the dissolution process is to mix the silk fiber obtained after degumming with a ternary solution composed of CaCl 2 -ethanol-water, and keep it warm for 0.5h at a temperature of 75°C ; The amount ratio of substances is 1:2:8.
其次,取质量分数为1%的丝素溶液,在慢速搅拌情况下向其中依次加入辣根过氧化酶和双氧水,其中共混溶液中最终辣根过氧化酶的浓度为10U/ml,双氧水的浓度为0.6mg/ml。Secondly, take the silk fibroin solution with a mass fraction of 1%, add horseradish peroxidase and hydrogen peroxide successively therein under slow stirring, wherein the final concentration of horseradish peroxidase in the blended solution is 10U/ml, hydrogen peroxide The concentration is 0.6mg/ml.
再次,将共混溶液迅速真空脱泡之后置于37℃水浴。一段时间之后即可得到丝素水凝胶。Again, the blended solution was quickly defoamed in vacuum and placed in a 37°C water bath. After a period of time, silk fibroin hydrogel can be obtained.
实施例2Example 2
一种丝素水凝胶材料,由下述制备方法制备而得。A silk fibroin hydrogel material is prepared by the following preparation method.
首先将天然蚕丝依次经过脱胶、溶解、透析、过滤和浓缩得到质量分数为4%的丝素水溶解。其中,溶解过程是将脱胶后得到的丝素纤维与CaCl2-乙醇-水组成的三元溶液混合,在75℃的温度条件下保温0.5h;三元溶液中,CaCl2、乙醇和水的物质的量比为1:2:8。Firstly, the natural silk is degummed, dissolved, dialyzed, filtered and concentrated to obtain silk fibroin with a mass fraction of 4%. Among them, the dissolution process is to mix the silk fiber obtained after degumming with a ternary solution composed of CaCl 2 -ethanol-water, and keep it warm for 0.5h at a temperature of 75°C ; The amount ratio of substances is 1:2:8.
其次,取质量分数为2%的丝素溶液,在慢速搅拌情况下向其中依次加入辣根过氧化酶和双氧水,其中共混溶液中最终辣根过氧化酶的浓度为10U/ml,双氧水的浓度为0.6mg/ml。Secondly, take the silk fibroin solution with a mass fraction of 2%, add horseradish peroxidase and hydrogen peroxide successively therein under slow stirring, wherein the final concentration of horseradish peroxidase in the blended solution is 10U/ml, hydrogen peroxide The concentration is 0.6mg/ml.
再次,将共混溶液迅速真空脱泡之后置于37℃水浴。一段时间之后即可得到丝素水凝胶。Again, the blended solution was quickly defoamed in vacuum and placed in a 37°C water bath. After a period of time, silk fibroin hydrogel can be obtained.
实施例3Example 3
一种丝素水凝胶材料,由下述制备方法制备而得。A silk fibroin hydrogel material is prepared by the following preparation method.
首先将天然蚕丝依次经过脱胶、溶解、透析、过滤和浓缩得到质量分数为4%的丝素水溶解。其中,溶解过程是将脱胶后得到的丝素纤维与CaCl2-乙醇-水组成的三元溶液混合,在75℃的温度条件下保温0.5h;三元溶液中,CaCl2、乙醇和水的物质的量比为1:2:8。Firstly, the natural silk is degummed, dissolved, dialyzed, filtered and concentrated to obtain silk fibroin with a mass fraction of 4%. Among them, the dissolution process is to mix the silk fiber obtained after degumming with a ternary solution composed of CaCl2-ethanol-water, and keep it warm for 0.5h at a temperature of 75°C; in the ternary solution, the content of CaCl2, ethanol and water The volume ratio is 1:2:8.
其次,取质量分数为3%的丝素溶液,在慢速搅拌情况下向其中依次加入辣根过氧化酶和双氧水,其中共混溶液中最终辣根过氧化酶的浓度为10U/ml,双氧水的浓度为0.6mg/ml。Secondly, take the silk fibroin solution with a mass fraction of 3%, add horseradish peroxidase and hydrogen peroxide successively therein under slow stirring, wherein the final concentration of horseradish peroxidase in the blended solution is 10U/ml, hydrogen peroxide The concentration is 0.6mg/ml.
再次,将共混溶液迅速真空脱泡之后置于37℃水浴。一段时间之后即可得到丝素水凝胶。Again, the blended solution was quickly defoamed in vacuum and placed in a 37°C water bath. After a period of time, silk fibroin hydrogel can be obtained.
对比例1Comparative example 1
一种水凝胶,其制作流程同实施例3,不同之处在于不添加双氧水。A kind of hydrogel, its production process is the same as embodiment 3, and the difference is that hydrogen peroxide is not added.
对比例2Comparative example 2
一种水凝胶,其制作流程同实施例3,不同之处在于不添加过辣根过氧化酶和双氧水。A kind of hydrogel, its production process is the same as embodiment 3, and difference is not to add horseradish peroxidase and hydrogen peroxide.
试验例1Test example 1
采用常规的方法测试实施例1-3和对比例1-2中得到水凝胶的宏观形貌,结果见图1。如图中所示,实施例1-3得到的丝素水凝胶透明度高,而对比例1和2丝素水凝胶呈乳白色。通过人为测量,其水凝胶的厚度约为5mm。The macroscopic morphology of the hydrogels obtained in Examples 1-3 and Comparative Examples 1-2 was tested by conventional methods, and the results are shown in FIG. 1 . As shown in the figure, the silk fibroin hydrogels obtained in Examples 1-3 have high transparency, while the silk fibroin hydrogels obtained in Comparative Examples 1 and 2 are milky white. Through artificial measurement, the thickness of its hydrogel is about 5mm.
图1上部分三幅图示出了本发明的优选示例中所制得水凝胶的透明效果。The three figures in the upper part of Fig. 1 show the transparent effect of the hydrogel prepared in the preferred example of the present invention.
图1下部分的五个图中,1-1%SF表示实施例1中采用1%质量分数的丝素溶液制作水凝胶;2-2%SF表示实施例2中采用2%质量分数的丝素溶液制作水凝胶;3-1%SF表示实施例3中采用3%质量分数的丝素溶液制作水凝胶;4-3%SF表示对比例1中采用3%质量分数的丝素溶液制作水凝胶;5-3%SF表示对比例2中采用3%质量分数的丝素溶液制作水凝胶。3D表示3天,SF表示丝素蛋白。Among the five figures in the lower part of Fig. 1, 1-1% SF represents the silk fibroin solution that adopts 1% mass fraction to make hydrogel in embodiment 1; 2-2% SF represents that adopts 2% mass fraction silk fibroin in embodiment 2 Silk fibroin solution makes hydrogel; 3-1%SF means adopting the silk fibroin solution of 3% mass fraction in embodiment 3 to make hydrogel; 4-3%SF means adopting the silk fibroin of 3% mass fraction in comparative example 1 Solution to make hydrogel; 5-3% SF means using 3% mass fraction of silk fibroin solution to make hydrogel in Comparative Example 2. 3D means 3 days, SF means silk fibroin.
试验例2Test example 2
采用倒置法记录实施例1-3的凝胶时间,结果如图2所示,而对比例1和2的凝胶时间(37℃)分别为40h和42h(未列入图中)。从图中可见,酶促催化交联反应明显缩短了丝素凝胶时间,提高了丝素材料的可注射性。The gel times of Examples 1-3 were recorded by the inversion method, and the results are shown in Figure 2, while the gel times (37°C) of Comparative Examples 1 and 2 were 40h and 42h respectively (not listed in the figure). It can be seen from the figure that the enzymatically catalyzed cross-linking reaction significantly shortens the gelation time of silk fibroin and improves the injectability of silk fibroin materials.
试验例3Test example 3
采用T9CS紫外可见光分光光度仪(北京普析通用仪器有限责任公司)测定实施例2不同状态下的可见光全波段透光率。其中去离子水作为对照组。从谱图中可见,在可见光的范围内,丝素水凝胶的透光率较高,其范围处于50~80%。A T9CS ultraviolet-visible spectrophotometer (Beijing Puxi General Instrument Co., Ltd.) was used to measure the full-band transmittance of visible light in different states of Example 2. Among them, deionized water was used as the control group. It can be seen from the spectrogram that in the range of visible light, the light transmittance of silk fibroin hydrogel is relatively high, ranging from 50% to 80%.
研究结果表明采用酶促催化交联方法制备出的丝素水凝胶凝胶时间明显缩短,所形成的水凝胶的透明度高。本发明制备的这类透明的丝素水凝胶材料扩展了丝素生物医用材料的应用范围,可作为医用敷料,体内可注射材料,体内可填充物以及用于组织修复等领域,具有良好的应用前景。The research results show that the gel time of silk fibroin hydrogel prepared by enzymatic catalytic cross-linking method is obviously shortened, and the transparency of the formed hydrogel is high. This kind of transparent silk fibroin hydrogel material prepared by the present invention expands the application range of silk fibroin biomedical materials, and can be used as medical dressings, injectable materials in vivo, fillers in vivo, and tissue repair and other fields, and has good properties. Application prospect.
尽管已用具体实施例来说明和描述了本发明,然而应意识到,在不背离本发明的精神和范围的情况下可以作出许多其它的更改和修改。因此,这意味着在所附权利要求中包括属于本发明范围内的所有这些变化和修改。While particular embodiments of the invention have been illustrated and described, it should be appreciated that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810308852.5A CN108478852A (en) | 2018-04-08 | 2018-04-08 | A kind of pharmaceutical products, the carrier for loading pharmaceutical products, hydrogel and its method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810308852.5A CN108478852A (en) | 2018-04-08 | 2018-04-08 | A kind of pharmaceutical products, the carrier for loading pharmaceutical products, hydrogel and its method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108478852A true CN108478852A (en) | 2018-09-04 |
Family
ID=63315307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810308852.5A Pending CN108478852A (en) | 2018-04-08 | 2018-04-08 | A kind of pharmaceutical products, the carrier for loading pharmaceutical products, hydrogel and its method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108478852A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109824922A (en) * | 2019-01-17 | 2019-05-31 | 湖北工程学院 | A kind of hydrogel material with infrared light response and preparation method thereof |
CN110464871A (en) * | 2019-08-21 | 2019-11-19 | 南开大学 | A kind of injection aquagel and preparation method thereof |
CN112159532A (en) * | 2020-07-03 | 2021-01-01 | 中国科学院大学温州研究院(温州生物材料与工程研究所) | Oxygen-containing hydrogel dressing and preparation and application thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101439206A (en) * | 2007-11-22 | 2009-05-27 | 郭倩 | Preparation of enzyme-catalyzed rapid-solidified hydrogel and use thereof |
WO2009148405A1 (en) * | 2008-06-05 | 2009-12-10 | Agency For Science, Technology And Research | Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide |
CN101864178A (en) * | 2010-06-17 | 2010-10-20 | 复旦大学 | A kind of injectable chemically cross-linked protein/polypeptide hydrogel and its preparation method |
CN102573944A (en) * | 2009-07-02 | 2012-07-11 | 亚洲大学校产学协力团 | In situ forming hydrogel and biomedical use thereof |
CN104004231A (en) * | 2014-06-12 | 2014-08-27 | 东南大学 | Biomacromolecule interpenetrating polymer network hydrogel and preparation method thereof |
CN104307040A (en) * | 2014-07-22 | 2015-01-28 | 中国人民解放军第三军医大学第一附属医院 | Injectable hydrogel with controlled release capacity and for tissue engineering, and application thereof |
CN106009709A (en) * | 2016-06-25 | 2016-10-12 | 南通纺织丝绸产业技术研究院 | Silk fibroin hydrogel adopting IPN (interpenetrating polymer network) structure and preparation method of silk fibroin hydrogel |
-
2018
- 2018-04-08 CN CN201810308852.5A patent/CN108478852A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101439206A (en) * | 2007-11-22 | 2009-05-27 | 郭倩 | Preparation of enzyme-catalyzed rapid-solidified hydrogel and use thereof |
WO2009148405A1 (en) * | 2008-06-05 | 2009-12-10 | Agency For Science, Technology And Research | Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide |
CN102573944A (en) * | 2009-07-02 | 2012-07-11 | 亚洲大学校产学协力团 | In situ forming hydrogel and biomedical use thereof |
CN101864178A (en) * | 2010-06-17 | 2010-10-20 | 复旦大学 | A kind of injectable chemically cross-linked protein/polypeptide hydrogel and its preparation method |
CN104004231A (en) * | 2014-06-12 | 2014-08-27 | 东南大学 | Biomacromolecule interpenetrating polymer network hydrogel and preparation method thereof |
CN104307040A (en) * | 2014-07-22 | 2015-01-28 | 中国人民解放军第三军医大学第一附属医院 | Injectable hydrogel with controlled release capacity and for tissue engineering, and application thereof |
CN106009709A (en) * | 2016-06-25 | 2016-10-12 | 南通纺织丝绸产业技术研究院 | Silk fibroin hydrogel adopting IPN (interpenetrating polymer network) structure and preparation method of silk fibroin hydrogel |
Non-Patent Citations (2)
Title |
---|
周宏湘 等编: "《染整新技术问答》", 30 April 1998, 中国纺织出版社 * |
赵群: "丝蛋白功能性水凝胶的制备和性能研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109824922A (en) * | 2019-01-17 | 2019-05-31 | 湖北工程学院 | A kind of hydrogel material with infrared light response and preparation method thereof |
CN109824922B (en) * | 2019-01-17 | 2021-11-16 | 湖北工程学院 | Hydrogel material with infrared light response and preparation method thereof |
CN110464871A (en) * | 2019-08-21 | 2019-11-19 | 南开大学 | A kind of injection aquagel and preparation method thereof |
CN112159532A (en) * | 2020-07-03 | 2021-01-01 | 中国科学院大学温州研究院(温州生物材料与工程研究所) | Oxygen-containing hydrogel dressing and preparation and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4667486B2 (en) | Water-soluble elastin crosslinking agent | |
Wei et al. | In situ fabrication of nerve growth factor encapsulated chitosan nanoparticles in oxidized bacterial nanocellulose for rat sciatic nerve regeneration | |
CN103272268B (en) | Antibacterial cornea repairing material and preparation method thereof | |
CN104013995B (en) | Oxidation chitosan graft modification pig dermis collagen micro-nano fiber film and preparation method thereof | |
CA2740136A1 (en) | Injectable in-situ crosslinked hydrogel and methods of making and using thereof | |
CN108478852A (en) | A kind of pharmaceutical products, the carrier for loading pharmaceutical products, hydrogel and its method | |
TWI245634B (en) | Preparation of a biodegradable thermal-sensitive gel system | |
CN106039416A (en) | Chitosan-sericin composite biological scaffold as well as preparation method and application thereof | |
CN111303452A (en) | Bionic antibacterial high-adhesion double-network hydrogel and preparation method and application thereof | |
Dong et al. | Electrospun nanofibrous membranes of recombinant human collagen type III promote cutaneous wound healing | |
CN101134784B (en) | Agarose and hyaluronic acid graft and its preparation method and application | |
CN116139331A (en) | Multifunctional wound repair dressing loaded with bioactive glass and preparation method thereof | |
CN115887742A (en) | Preparation method of antibacterial functional collagen-based injectable self-healing hydrogel | |
CN104548201B (en) | A kind of corneal tissue repair material and preparation method thereof | |
CN115429935B (en) | Injectable cross-linked chondroitin sulfate hydrogel and preparation method thereof | |
WO1996003147A1 (en) | Synthesis of chemical gels from polyelectrolyte polysaccharides by gamma-irradiation | |
CN101301494A (en) | A kind of hydrogel material for central nervous repair and its preparation method | |
CN107854729A (en) | A kind of fibroin albumen base self-healing hydrogel and preparation method thereof | |
Zheng et al. | Carp scales derived double cross-linking hydrogels achieve collagen peptides sustained-released for bone regeneration | |
CN114225113B (en) | Degradable artificial dura mater with double-layer structure and preparation method thereof | |
CN110804192A (en) | A kind of cellulose antibacterial hydrogel and preparation method thereof | |
CN110464871A (en) | A kind of injection aquagel and preparation method thereof | |
Dooley et al. | Dense chitosan surgical membranes produced by a coincident compression-dehydration process | |
KR20060009325A (en) | Injectable Insoluble Globin Implant | |
CN110711264A (en) | Composite material, medical adhesive, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180904 |
|
RJ01 | Rejection of invention patent application after publication |